{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Valspodar",
  "nciThesaurus": {
    "casRegistry": "121584-18-7",
    "chebiId": "",
    "chemicalFormula": "C63H111N11O12",
    "definition": "An analogue of cyclosporin-A. Valspodar inhibits p-glycoprotein, the multidrug resistance efflux pump, thereby restoring the retention and activity of some drugs in some drug-resistant tumor cells. This agent also induces caspase-mediated apoptosis.",
    "fdaUniiCode": "Q7ZP55KF3X",
    "identifier": "C1405",
    "preferredName": "Valspodar",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [],
    "synonyms": [
      "6-[(2S,4R,6E)-4-Methyl-2-(methylamino)-3-oxo-6-octenoic Acid]cyclosporin D",
      "Amdray",
      "Cyclo((2S,4R,6E)-4-methyl-2-(methylamino)-3-oxo-6-octenoyl)-L-valyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-me",
      "PSC 833",
      "PSC-833",
      "PSC833",
      "SZD PSC 833",
      "VALSPODAR",
      "VP16",
      "Valspodar"
    ]
  }
}